Due to compensatory mechanisms in BAF‐complex assembly, these loss‐of‐function somatic mutations within the cancer cells may lead to cancer‐specific synthetic lethality that can be leveraged for treatment approaches with a greater therapeutic index. The gene discussed is BANF1; the disease is cancer.